{
    "2018-10-19": [
        [
            {
                "time": "2018-01-02",
                "original_text": "The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Pricing Offering, LogicBio To Debut",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Positive Liver Drug Trials",
                        "Krytstal Pricing Offering",
                        "LogicBio"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Today's Research Reports on Trending Tickers: Pfizer and Novartis",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Novartis",
                        "Research Reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novartis Announces Phase II Preliminary Results Of GEOMETRY Mono-1 Trial",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Phase II",
                        "GEOMETRY Mono-1 Trial",
                        "Preliminary Results"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novartis: Lutathera NETTER-1 Data Shows Improvement In PFS - Quick Facts",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Lutathera",
                        "NETTER-1 Data",
                        "Improvement In PFS"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}